Avicena Systems

About Avicena Systems

Avicena Systems is a startup that operates in the healthcare technology sector, specifically in the field of biosecurity. The company has developed advanced biosecurity platforms that are designed to protect communities and economies. These platforms are capable of conducting up to 100,000 tests per day with a high accuracy rate of 98% for identifying infectious individuals. The tests are conducted using a method called RT-LAMP, which is a type of molecular assay that can identify the presence of a specific virus or bacteria in a sample.

Avicena Systems serves a wide range of clients, including healthcare providers, laboratories, and potentially government agencies. Its business model revolves around the sale of its proprietary testing platforms, the Avicena Sentinel. The Sentinel comes in two versions: the ULTRA, which is designed for high-volume testing, and the Mini, which is more compact and suited for remote locations.

The company's platforms are not only fast, but they also offer the ability to screen for multiple pathogens simultaneously. This makes them a valuable tool in the fight against infectious diseases. The Avicena Sentinel is intended for use by trained laboratory professionals and requires specific reagents and workflows that have been approved by regulatory agencies and Avicena Systems itself.

In terms of revenue, Avicena Systems likely makes money through the sale of its testing platforms and the necessary reagents and workflows. The company may also generate income through service contracts or partnerships with healthcare providers and laboratories.